Literature DB >> 23420916

Distinguishing Lyme from septic knee monoarthritis in Lyme disease-endemic areas.

Julia K Deanehan1, Amir A Kimia, Sharman P Tan Tanny, Matthew D Milewski, Paul G Talusan, Brian G Smith, Lise E Nigrovic.   

Abstract

OBJECTIVE: Because Lyme and septic arthritis may present similarly, we sought to identify children with knee monoarthritis at low risk for septic arthritis who may not require arthrocentesis.
METHODS: We performed a retrospective study of children with knee monoarthritis presenting to 1 of 2 pediatric centers, both located in Lyme disease-endemic areas. Septic arthritis was defined by a positive result on synovial fluid culture or synovial fluid pleocytosis with a positive blood culture result. Lyme arthritis was defined as a positive Lyme serologic result or physician-documented erythema migrans rash. All other children were considered to have other inflammatory arthritis. A clinical prediction model was derived by using recursive partitioning to identify children at low risk for septic arthritis, and the model was then externally validated.
RESULTS: We identified 673 patients with knee monoarthritis; 19 (3%) had septic arthritis, 341 (51%) had Lyme arthritis, and 313 (46%) had other inflammatory arthritis. The following predictors of knee septic arthritis were identified: peripheral blood absolute neutrophil count ≥10 × 10(3) cells per mm(3) and an erythrocyte sedimentation rate ≥40 mm/hour. In the validation population, no child with a absolute neutrophil count <10 × 10(3) cells per mm(3) and an erythrocyte sedimentation rate <40 mm/hour had septic arthritis (sensitivity: 6 of 6 [100%], 95% confidence interval [CI]: 54-100; specificity: 87 of 160 [54%], 95% CI: 46-62). Overall, none of the 19 children with septic arthritis were classified as low risk (10%, 95% CI: 0-17).
CONCLUSIONS: Laboratory criteria can be used to identify children with knee monoarthritis at low risk for septic arthritis who may not require diagnostic arthrocentesis.

Entities:  

Mesh:

Year:  2013        PMID: 23420916     DOI: 10.1542/peds.2012-2531

Source DB:  PubMed          Journal:  Pediatrics        ISSN: 0031-4005            Impact factor:   7.124


  18 in total

Review 1.  [Molecular pathological diagnostics of infections in orthopedic pathology].

Authors:  J Kriegsmann; N Arens; C Altmann; M Kriegsmann; R Casadonte; M Otto
Journal:  Pathologe       Date:  2014-11       Impact factor: 1.011

2.  Evaluation of the C6 Lyme Enzyme Immunoassay for the Diagnosis of Lyme Disease in Children and Adolescents.

Authors:  Susan C Lipsett; John A Branda; Alexander J McAdam; Louis Vernacchio; Caroline D Gordon; Catherine R Gordon; Lise E Nigrovic
Journal:  Clin Infect Dis       Date:  2016-06-28       Impact factor: 9.079

3.  Evaluation of the Modified Two-Tiered Testing Method for Diagnosis of Lyme Disease in Children.

Authors:  Susan C Lipsett; John A Branda; Lise E Nigrovic
Journal:  J Clin Microbiol       Date:  2019-09-24       Impact factor: 5.948

4.  Acute inflammatory arthritis: monoarthritis risk stratification in Lyme disease.

Authors:  Robert T Schoen
Journal:  Nat Rev Rheumatol       Date:  2013-04-09       Impact factor: 20.543

5.  Accuracy of Clinician Suspicion of Lyme Disease in the Emergency Department.

Authors:  Lise E Nigrovic; Jonathan E Bennett; Fran Balamuth; Michael N Levas; Rachel L Chenard; Alexandra B Maulden; Aris C Garro
Journal:  Pediatrics       Date:  2017-12       Impact factor: 7.124

6.  False Positive Lyme Disease IgM Immunoblots in Children.

Authors:  Paul M Lantos; Susan C Lipsett; Lise E Nigrovic
Journal:  J Pediatr       Date:  2016-05-04       Impact factor: 4.406

7.  Hip Synovial Fluid Cell Counts in Children From a Lyme Disease Endemic Area.

Authors:  Arianna H Dart; Kenneth A Michelson; Paul L Aronson; Aris C Garro; Thomas J Lee; Kimberly M Glerum; Peter A Nigrovic; Mininder S Kocher; Richard G Bachur; Lise E Nigrovic
Journal:  Pediatrics       Date:  2018-04-18       Impact factor: 7.124

8.  Poor Positive Predictive Value of Lyme Disease Serologic Testing in an Area of Low Disease Incidence.

Authors:  Paul M Lantos; John A Branda; Joel C Boggan; Saumil M Chudgar; Elizabeth A Wilson; Felicia Ruffin; Vance Fowler; Paul G Auwaerter; Lise E Nigrovic
Journal:  Clin Infect Dis       Date:  2015-07-20       Impact factor: 9.079

9.  The Positive Predictive Value of Lyme Elisa for the Diagnosis of Lyme Disease in Children.

Authors:  Susan C Lipsett; Nira R Pollock; John A Branda; Caroline D Gordon; Catherine R Gordon; Paul M Lantos; Lise E Nigrovic
Journal:  Pediatr Infect Dis J       Date:  2015-11       Impact factor: 2.129

10.  The clinical presentation, treatment and outcome of serologically confirmed paediatric Lyme disease in the Republic of Ireland over a 5-year period: a retrospective cohort study.

Authors:  Karina M Forde; Joanne O'Gorman; Patrick J Gavin; Matthew S Dryden; Deirbhile Keady; Belinda Hanahoe; Colm McDonnell; Lorraine Power; Bartley Cryan; James Sweeney; Karl F Conyard; Michael J O'Grady
Journal:  Eur J Clin Microbiol Infect Dis       Date:  2020-10-11       Impact factor: 3.267

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.